Beckman Coulter Clinical Diagnostics Earns Eight Top Rankings in China Medical Equipment Awards, Pioneering Future Hospital Diagnostics

From March 15 to 17, the 14th China Medical Equipment Industry Data Release Conference, hosted by China Medical Equipment Magazine and the Beijing Smart Healthcare Technology Innovation Alliance, was successfully held in Beijing.

In the “2023 Annual Data Survey Report on China’s Medical Equipment Industry,” Beckman Coulter Clinical Diagnostics ranked first in the service survey for laboratory equipment in the ownership rate category (10% > ownership rate ≥ 1%), as well as in the ownership rate (10% > retention rate ≥ 5%), satisfaction, training satisfaction, and the composite ranking for tiered hospital retention rates in tertiary and secondary hospitals ranked first; the tiered retention rate in primary medical institutions and the Net Promoter Score (NPS) for emergency laboratory testing also ranked first.

After the meeting,Sun Xianbing, Head of the Customer Service Center for Danaher China’s Diagnostics Platform and Director of Customer Value Solutions for Beckman Coulter Clinical Diagnostics in ChinaMr. [Name] was interviewed by VCBeat.

Sun Xianbing stated that customer recognition of a company is never determined by a single factor, but rather reflects the comprehensive value delivered to customers. As one of the global leaders in the field of in vitro diagnostics, Beckman Coulter’s core strategy for establishing long-term, high-value partnerships with customers lies in precisely responding to service value and enhancing overall competitiveness.

Upholding the mission of “Unceasing Medical Exploration, Wholehearted Diagnostic Commitment,” Beckman Coulter focuses on transformative technological innovation, continuously advancing product innovation and R&D to deliver high-quality products and services. By closely attending to customer needs and constantly innovating service offerings, the company provides reliable service solutions. For instance, it has further expanded its diagnostic portfolio to offer more customers precise and rapid diagnostic and treatment solutions; it has also continued to apply mature DBS tools and digital intelligence software to laboratory process improvement and risk assessment, enabling more customers to genuinely experience the convenience of “cost reduction and efficiency enhancement.”

Beckman Coulter’s commitment to its customers and patients is to continuously deliver high-quality products and enhance and expand its capacity to serve them. In March, Beckman Coulter launched two new domestically produced products—the DxA 5000Fit Automated Sample Processing System and the DxC 700AU Automated Chemistry Analyzer—addressing many pain points in medical laboratories, such as complex specimen preparation workflows, variability in manual operations, and challenges in achieving standardization and automation, thereby tackling core issues in China’s IVD industry.

Sun Xianbing emphasized that in an era of rapid medical advancement, “professionalism, efficiency, and innovation” represent the core value demands of Chinese healthcare providers and patients, as well as the value proposition of Beckman Coulter’s after-sales services. Adhering to its service philosophy of being “customer-centric and committed to becoming a trusted value partner for customers,” the company has established a robust framework combining “comprehensive user training experiences with a well-developed after-sales skills enhancement system,” and has built a specialized and diversified service team.

Beckman Coulter remains committed to addressing customer needs, continuously strengthening its professional expertise, optimizing and expanding service models, and collaborating with customers to build a value-driven ecosystem, thereby solidifying the “professional” guarantee of service quality.

Furthermore, Beckman Coulter has developed a diversified service portfolio integrating “intelligent manufacturing in services” and “digital innovation,” continuously accelerating the enhancement of laboratory service “efficiency.” By focusing on and refining “laboratory equipment lifecycle management + laboratory operational risk management,” and deeply exploring and establishing “innovation” metrics for healthcare systems, the company strives to become a trusted value partner for its customers while continuously upgrading service quality.

Smart Service Manufacturing: Intelligent Transformation and Innovation in ServicesOver its 40 years in China, Beckman Coulter’s Gold Standard Service has evolved through three phases: 1.0 After-Sales Support, 2.0 Customer Care, and 3.0 Co-Creation of Value. Throughout this journey, the content and format of its services have been continuously refined to precisely address customer pain points, driving ongoing reform and innovation.

Accelerated by the “Healthy China” strategy, Danaher’s Medical Diagnostics Platform has officially inaugurated its R&D and manufacturing base in Suzhou. This facility rapidly localizes the production of flagship instruments and reagents while achieving true integration of local R&D, manufacturing, and services, enabling more customers to experience the qualitative leap of “Intelligent Manufacturing in China.”

Sun Xianbing stated that Beckman Coulter will keep pace with the times, continuously innovate its service solutions, achieve resource sharing across medical diagnostics, life sciences, and biotechnology, grow together with China’s medical device market, and jointly accelerate the development of diagnosis and treatment in future hospitals.